MingDu Intelligent closes RMB80m Series A+ round led by Zheshang Venture Capital

On July 22, MingDu Intelligent, a pharmaceutical enterprise digital transformation services provider, announced the completion of its Series A+ round worth 80 million yuan.

On July 22, MingDu Intelligent, a pharmaceutical enterprise digital transformation services provider, announced the completion of its Series A+ round worth 80 million yuan.

The round was led by Zheshang Venture Capital, with participation from China Merchants Venture and Topping Capital.

Proceeds from this round of financing will be used primarily for market expansion, accelerating product development and iteration.

MingDu Intelligent provides full life-cycle management solutions to pharmaceutical companies. The company aims to provide solutions covering research and development, production, warehousing and logistics, enabling the drug makers to simplify and increase the efficiency of the application, production and registration of pharmaceutical products

MingDu Intelligent’s digital solutions have served more than 100 top-tier pharmaceutical enterprises, including CR Sanjiu, Livzon, Shanghai Pharmaceuticals, Wuhan Jianmin Group, Science Sun, Zhejiang Medicine, among others, involving biopharmaceuticals, traditional Chinese medicines, chemicals, vaccines and other types of drugs.

Disclaimer: This is an article created by Michael Liang for Chinasdg.org. You can find the original article here: https://chinasdg.org/2020/07/25/mingdu-intelligent-closes-rmb80m-series-a-round-led-by-zheshang-venture-capital/.

Leave a Reply

Please Login to Comment